Conventional influenza vaccination compared to MF59 adjuvanted subunit vaccine

被引：0
|
作者：
Torrecilla Rojas, Maria Amparo [1 ]
Pedregal Gonzalez, Miguel [2 ]
Garcia Rodriguez, Fermin [3 ]
Ruiz Fernandez, Josefa [3 ]
机构：
[1] Unidad Salud Publ, Dist Sanitario Condado C, Huelva, Spain
[2] Unidad Docente Med Familiar & Comunitaria, Dist Sanitario Huelva Co, Huelva, Spain
[3] Consejeria Salud Junta Andalucia, Secretaria Gen Salud Publ & Participac, Seville, Spain
来源：
ATENCION PRIMARIA | 2009年 / 41卷 / 12期
关键词：
ELDERLY SUBJECTS; IMMUNOGENICITY; SPLIT; PROTECTION; SAFETY; VIRUS; REACTOGENICITY; PNEUMONIA; AGE;
D O I：
10.1016/j.aprim.2009.06.008
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：695 / 697
页数：3
相关论文
共 50 条
  • [1] MF59™-adjuvanted subunit influenza vaccine:: an improved interpandemic influenza vaccine for vulnerable populations
    Barbera, Joan Puig
    Vidal, David Gonzalez
    EXPERT REVIEW OF VACCINES, 2007, 6 (05) : 659 - 665
  • [2] Influenza vaccination in children primed with MF59®-adjuvanted or non-adjuvanted seasonal influenza vaccine
    Vesikari, Timo
    Forsten, Aino
    Arora, Ashwani
    Tsai, Theodore
    Clemens, Ralf
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (08) : 2102 - 2112
  • [3] Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects
    Li R.
    Fang H.
    Li Y.
    Liu Y.
    Pellegrini M.
    Podda A.
    Immunity & Ageing, 5 (1)
  • [4] Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects
    Gasparini, R
    Pozzi, T
    Montomoli, E
    Fragapane, E
    Senatore, F
    Minutello, M
    Podda, A
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2001, 17 (02) : 135 - 140
  • [5] Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects
    R. Gasparini
    T. pozzi
    E. Montomoli
    E. Fragapane
    F. Senatore
    M. Minutello
    A. Podda
    European Journal of Epidemiology, 2001, 17 : 135 - 140
  • [6] MF59™-adjuvanted seasonal influenza vaccine in young children
    Puig-Barbera, Joan
    Perez-Vilar, Silvia
    Diez-Domingo, Javier
    EXPERT REVIEW OF VACCINES, 2011, 10 (11) : 1519 - 1528
  • [7] Cost effectiveness of MF59 adjuvanted influenza vaccine in France
    Chambers, J.
    Eijgelshoven, I
    Piercy, J.
    Wait, S.
    VALUE IN HEALTH, 2007, 10 (03) : A163 - A164
  • [8] Fluad (R)-MF59 (R)-Adjuvanted Influenza Vaccine in Older Adults
    Tsai, Theodore F.
    INFECTION AND CHEMOTHERAPY, 2013, 45 (02): : 159 - 174
  • [9] INTRANASAL VACCINATION WITH SUBUNIT INFLUENZA VACCINE COMBINED WITH THE ADJUVANTS LTK63 OR MF59
    BARCHFELD, GL
    HESSLER, AL
    HIGGINS, DA
    CATALDO, D
    TRAQUINA, P
    PIZZA, M
    DEMAGISTRIS, MT
    DOUCE, G
    DOUGAN, G
    VANNEST, G
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 254 - 254
  • [10] Increased immunogenicity with an MF59-adjuvanted influenza vaccine (FLUAD®) compared with a conventional subunit vaccine (Agrippal®) in renal transplant recipients
    Pollok, M
    Geiger, H
    Floege, J
    Paschke, R
    Abendroth, D
    Blenzle, U
    Ypma, E
    Banzhoff, A
    OPTIONS FOR THE CONTROL OF INFLUENZA V, 2004, 1263 : 453 - 456
12345